Arcadia Biosciences, Inc.
202 Cousteau Place
133 articles with Arcadia Biosciences, Inc.
Arcadia Biosciences Announces Closing of $7.5 Million Registered Direct Offering Priced At-the-Market
Net Proceeds to Fuel Hemp Research, Innovation and Scale-Up of GoodWheat™
Company launches new business unit, Arcadia Specialty Genomics™, to apply its advanced plant breeding and gene editing expertise to cannabis
Arcadia Biosciences Announces Date of First-Quarter 2019 Financial Results and Business Highlights Conference Call
Plans to release its first-quarter 2019 financial and business results after market close on May 8, 2019.
4/12/2019Biopharma companies tap new hires to assume roles in leadership positions, with additions at Metrion, JDRF, Ribometrix, and more.
Experienced R&D strategist brings deep expertise in advanced breeding and gene editing technologies
Arcadia Biosciences Announces Fourth-Quarter and Full-Year 2018 Financial Results and Business Highlights
Arcadia Biosciences, Inc. (Nasdaq: RKDA), a food ingredient company and proven leader in agricultural innovation, improving the quality and nutritional content of crops, today released its financial and business results for the fourth quarter and full year of 2018.
Highly favorable response to pre-commercial introduction of HB4 technology
Arcadia Biosciences, Inc. announced that it will be featured as a presenting company at The Spring Investor Summit.
SONOVA GLA offers cat food manufacturers a sustainable, plant-based source of essential omega-6 fatty acid
The company’s new cannabis-dedicated operating unit, Arcadia Specialty Genomics, will commence research this April with a new 10-acre hemp cultivation facility.
Arcadia Biosciences, a Leader in Advanced Agricultural Breeding and Gene Optimization, Announces New Business Unit Dedicated to Cannabis
Arcadia Specialty Genomics to bring standardization and optimization to America’s cannabis crop with a focus on improved plant quality, resiliency and yield.
Winter planting expands acres and builds supply for commercial launch
Arista Cereal Technologies Announces Dismissal of Patent Dispute With Arcadia Biosciences Over High Fiber Wheat
Arista Cereal Technologies Pty Ltd (ARISTA) announces that the lawsuit initiated by Arcadia Biosciences Inc. against ARISTA in the District Court for the Southern District of New York (SDNY) has been dismissed.
Arcadia Biosciences, Inc. announced that it will be featured as a presenting company at NobleConXV, Noble Capital Markets’ Fifteenth Annual Investor Conference, at the W Hotel in Fort Lauderdale, Florida.
Company’s global commercialization plans for GoodWheat™ portfolio of innovative wheat ingredients remain on track
Arcadia Biosciences and Ardent Mills Announce Collaboration to Develop and Commercialize Wheat Innovations
Initial project focuses on extending shelf life of whole wheat and promoting whole grain consumption
Verdeca Receives Approval to Integrate HB4® Drought Tolerant Soybeans with Herbicide Tolerance in Argentina
Novel trait stack will help growers facing climate and production challenges
Arcadia Biosciences Announces Date of Third-Quarter 2018 Financial Results and Business Highlights Conference Call
Arcadia Biosciences, Inc. (Nasdaq: RKDA), an agricultural food ingredient company, today announced that it will release its third-quarter 2018 financial and business results after market close on November 7, 2018.
Arcadia Biosciences Receives US Patent for Extended Shelf Life Wheat Trait Designed to Increase Whole Grain Consumption and Minimize Waste
Newest technology expands company’s GoodWheat™ portfolio of high-value, functional wheat ingredients
Verdeca’s HB4® soybean trait to help growers overcome challenging climate conditions